Sentinel Oncology is a fully integrated drug discovery company seeking to develop high quality drugs andidates for partnering with the pharmaceutical and biotechnology sectors. Their business model is collaborative and they partner with organisations who can maximise the value of our programmes.
|Partner||Seattle Genetics Innovate UK|
|Investment Portfolio||Pre-Fund Investment|
|Co-Investors||Wellcome Trust Business Angels|